Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BLEIBERG H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Caroli-Bosc, FX; Van Laethem, JL; Michel, P; Gay, F; Hendlisz, A; Forget, F; Bleiberg, H
      A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas

      EUROPEAN JOURNAL OF CANCER
    2. Buecher, B; Bleiberg, H
      Review article: non-systemic chemotherapy in the treatment of colorectal cancer - portal vein, hepatic arterial and intraperitoneal approaches

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    3. Bensmaine, MA; Marty, M; de Gramont, A; Brienza, S; Levi, F; Ducreux, M; Francois, E; Gamelin, E; Bleiberg, H; Cvitkovic, E
      Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

      BRITISH JOURNAL OF CANCER
    4. Van den Neste, E; de Valeriola, D; Kerger, J; Bleiberg, H; Kusenda, Z; Brassinne, C; Bartholomeus, S; Selleslags, J; Hennebert, P; Wythouck, H; Cazenave, I; Lefresne-Soulas, F; Piccart, M
      A Phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors

      CLINICAL CANCER RESEARCH
    5. Bleiberg, H
      A new class of antiemetics: the NK-1 receptor antagonists

      CURRENT OPINION IN ONCOLOGY
    6. Misset, JL; Bleiberg, H; Sutherland, W; Bekradda, M; Cvitkovic, E
      Oxaliplatin clinical activity: a review

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    7. Bensmaine, MA; de Gramont, A; Brienza, S; Marty, M; Levi, F; Ducreux, M; Francois, E; Gamelin, E; Bleiberg, H; Bleuzen, P; Simon, J; Cvitkovic, E
      Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/- folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

      EUROPEAN JOURNAL OF CANCER
    8. Vanhoefer, U; Rougier, P; Wilke, H; Ducreux, MP; Lacave, AJ; Van Cutsem, E; Planker, M; Dos Santos, JG; Piedbois, P; Paillot, B; Bodenstein, H; Schmoll, HJ; Bleiberg, H; Nordlinger, B; Couvreur, ML; Baron, B; Wils, JA
      Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European organization for research and treatment of cancer gastrointestinal tract cancer cooperative group

      JOURNAL OF CLINICAL ONCOLOGY
    9. Bleiberg, H
      Adjuvant therapy in high-risk colon cancer

      SEMINARS IN ONCOLOGY
    10. Freyer, G; Rougier, P; Bugat, R; Droz, JP; Marty, M; Bleiberg, H; Mignard, D; Awad, L; Herait, P; Culine, S; Trillet-Lenoir, V
      Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

      BRITISH JOURNAL OF CANCER
    11. Bleiberg, H
      CPT-11 in gastrointestinal cancer

      EUROPEAN JOURNAL OF CANCER
    12. Van Cutsem, E; Cunningham, D; Huinink, WWT; Punt, CJA; Alexopoulos, CG; Dirix, L; Symann, M; Blijham, GH; Cholet, P; Fillet, G; Van Groeningen, C; Vannetzel, JM; Levi, F; Panagos, G; Unger, C; Wils, J; Cote, C; Blanc, C; Herait, P; Bleiberg, H
      Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

      EUROPEAN JOURNAL OF CANCER
    13. Brienza, S; Bensmaine, MA; Soulie, P; Louvet, C; Gamelin, E; Francois, E; Ducreux, M; Marty, M; Andre, T; de Braud, F; Bleiberg, H; Segal, V; Itzhaki, M; Cvitkovic, E
      Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program

      ANNALS OF ONCOLOGY
    14. Primrose, JN; Bleiberg, H; Daniel, F; Van Belle, S; Mansi, JL; Seymour, M; Johnson, PW; Neoptolemos, JP; Baillet, M; Barker, K; Berrington, A; Brown, PD; Millar, AW; Lynch, KP
      Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

      BRITISH JOURNAL OF CANCER
    15. Bleiberg, H; Gerard, B
      Current and new systemic treatment of hepatobiliary tumors

      MALIGNANT LIVER TUMORS
    16. BLEIBERG H
      SHOULD THERE BE MASS-SCREENING USING FECAL OCCULT BLOOD-TESTS FOR COLORECTAL-CANCER - ARBITER

      European journal of cancer
    17. BLEIBERG H; DUCHATEAU J; MBON JBN; GERARD B; BRON D; DEBUSSCHER L; STRYCKMANS P
      INCREASED INCIDENCE OF LYMPHOMAS AND CARCINOMAS IN PATIENTS WITH CELIAC-DISEASE

      European journal of cancer
    18. BLEIBERG H; HULSTAERT F; BUYSE M; DEKEYSER P
      TROPISETRON IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING OVER 6 COURSES OF EMETOGENIC CHEMOTHERAPY

      Anti-cancer drugs
    19. GERARD B; BLEIBERG H; VANDAELE D; GIL T; HENDLISZ A; DILEO A; FERNEZ B; BRIENZA S
      OXALIPLATIN COMBINED TO 5-FLUOROURACIL AND FOLINIC ACID - AN EFFECTIVE THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

      Anti-cancer drugs
    20. BLEIBERG H
      CONTINUING THE FIGHT AGAINST ADVANCED COLORECTAL-CANCER - NEW AND FUTURE TREATMENT OPTIONS

      Anti-cancer drugs
    21. GOEDHALS L; HERON JF; KLEISBAUER JP; PAGANI O; SESSA C; GIGER K; CAVALLI F; LUDWIG C; AAPRO M; BLEIBERG H; DEWASH G; DICATO M; TAGNON A; VANSTRAELEN D; VINDEVOGHEL A; ABRATT R; FALKSON G; BARLEY V; CARMICHAEL J; COLEMAN R; DAVIDSON N; GRIEVE R; HARPER P; ROBERTS J; RUSTIN G; NAMAN H; SCHNEIDER M; NOBLE A; NETTER P; CUPISSOL D; BALMES P; CALS L; KHAYAT D; CATIMEL G; DUTIN JP; BOUFETTE P; ADENIS L; MISSET J; COLLERY P; NOUVET G; CHAVAILLON JM; BLANCHON F; POIRIER R; ARNAUD A; LECAER H; CARLES P; MUIR J; BONNAUD F; MARQUESTE L; CLAVIER J; GUERIN J; TAYTARD A; KEIZER H; NORTIER J; SLEE P; WILS J; RODENBURG C; BURGHOUTS J; DEWIT R; GARCIAGIRON C; JIMENEZLACAVE A; CRUZHERNANDEZ J; MASSUTISUREDA B; HANS K; FUCHS R; KRIEGMAIR M; SCHULLER J; LAHOUSEN M; PANNUTI F; MONFARDINI S; NILSSON S
      CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY

      Annals of oncology
    22. BLEIBERG H
      REVIEW OF COLORECTAL (CRC) TRIALS IN EUROPE - DURABLE ACHIEVEMENTS FUTURE STUDIES

      Annals of oncology
    23. KERGER J; DEVALERIOLA D; BLEIBERG H; BARTHOLOMEUS S; BRASSINNE C; WYTHOUCK H; SOULAS F; CAZENAVE I; PICCART M
      CLINICAL AND PHARMACOKINETIC PHASE-I STUDY OF THE COMBINATION OF DOCETAXEL (TXT), CISPLATIN (DDP) AND FLUOROURACIL (5-FU) IN PATIENTS WITH SOLID TUMORS

      Annals of oncology
    24. GRIMALDI C; BLEIBERG H; GAY F; MESSNER M; ROUGIER P; KOK TC; CIRERA L; CERVANTES A; DEGREVE J; PAILLOT B; BUSET M; NITTI D; SAHMOUD T; DUEZ N; WILS J
      EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL

      Journal of clinical oncology
    25. BLEIBERG H; SAHMOUD T; DILEO A; CUNNINGHAM D; ROUGIER P
      ADEQUATE NUMBER OF PATIENTS ARE NEEDED TO EVALUATE ADJUVANT TREATMENTIN GASTRIC-CANCER

      Journal of clinical oncology
    26. BAKER J; BLEIBERG H; HUTCHISON G; JACKMAN A; KERR D; LABIANCA R; MACDONALD J; MEYER HJ; MINSKY B; NORDLINGER B; ROUGIER P; SMITS S; SOBRERO A; TAYLOR I; VERWEIJ J
      AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997)

      Annales chirurgiae et gynaecologiae
    27. WILS J; SAHMOUD T; SOBRERO A; BLEIBERG H; AHMEDZAI S; BLAZEBY J; BLIJHAM G; CONROY T; CUNNINGHAM D; CURRAN D; DIAZRUBIO E; DUCREUX M; EVANS J; GLIMELIUS B; HUTCHINSON G; KERR D; KIEBERT G; KOHNE H; LABIANCA R; LANGENDIJK R; NITTI D; NORDLINGER B; ROUGIER P; SCHEITHAUER W; SCHMOLL HJ; VANCUTSEM E; WAGENER T; WILKE J; MARINUS A; THERASSE P
      EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG

      Tumori
    28. ROUGIER P; VANCUTSEM E; BAJETTA E; NIEDERLE N; POSSINGER K; LABIANCA R; NAVARRO M; MORANT R; BLEIBERG H; WILS J; AWAD L; HERAIT P; JACQUES C
      RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER

      Lancet
    29. BLEIBERG H; DEGRAMONT A
      OXALIPLATIN PLUS 5-FLUOROURACIL - CLINICAL-EXPERIENCE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

      Seminars in oncology
    30. BLEIBERG H
      EDRECOLOMAB (MONOCLONAL-ANTIBODY 17-1A) - A VIEWPOINT BY BLEIBERG,HARRY

      Drugs
    31. BLEIBERG H
      OXALIPLATIN (L-OHP) - A NEW REALITY IN COLORECTAL-CANCER

      British Journal of Cancer
    32. Bleiberg, H
      Can chemotherapy improve the quality of life of patients with advanced colorectal cancer?

      EUROCANCER 98
    33. BLEIBERG H; CONROY T; PAILLOT B; LACAVE AJ; BLIJHAM G; JACOB JH; BEDENNE L; NAMER M; DEBESI P; GAY F; COLLETTE L; SAHMOUD T
      RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER

      European journal of cancer
    34. BLEIBERG H
      SHOULD PATIENTS WITH ADVANCED COLORECTAL-CANCER BE TREATED WITH CHEMOTHERAPY - ARBITER

      European journal of cancer
    35. BLEIBERG H
      COLORECTAL-CANCER - IS THERE AN ALTERNATIVE TO 5-FU

      European journal of cancer
    36. BLEIBERG H; GERARD B; WILS J; BLIJHAM G; DIAZRUBIO E; HERRMANN R; KERR D; LABIANCA R; ROUGIER P; WILKE HJ; WILKING N
      GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE

      European journal of cancer
    37. BLEIBERG H
      NEW DRUGS AND THEIR POSSIBLE IMPACT ON PATIENT OUTCOME

      European journal of cancer
    38. BLEIBERG H; GERARD B; HENDLISZ A; JAGODZINSKI R
      NONSURGICAL TREATMENT OF CANCER OF THE PANCREAS

      Journal de chirurgie
    39. BLEIBERG H; JEZIORSKY K; HENDLISZ A; GERARD B
      IMPORTANCE OF RADIOTHERAPY FOR GASTRIC-CANCER

      Bulletin du cancer
    40. PUNT CJA; VOEST EE; TUENI E; VANOOSTEROM AT; BACKX A; DEMULDER PHM; HECQUET B; LUCAS C; GERARD B; BLEIBERG H
      PHASE IB STUDY OF DOXORUBICIN IN COMBINATION WITH THE MULTIDRUG-RESISTANCE REVERSING AGENT S9788 IN ADVANCED COLORECTAL AND RENAL-CELL CANCER

      British Journal of Cancer
    41. ROUGIER P; VANPOTTELSBERGHE C; KOK T; PAILLOT B; WAGENER T; DEGREVE J; FABRI MC; GERARD B; VANGLABBEKE M; BLEIBERG H
      FOTEMUSTINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, A PHASE-II TRIAL FROM THE EORTC-GITCCG (EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP)

      European journal of cancer
    42. AUDHUY B; CAPPELAERE P; MARTIN M; CERVANTES A; FABBRO M; RIVIERE A; KHAYAT D; BLEIBERG H; FARALDI M; CLAVERIE N
      A DOUBLE-BLIND, RANDOMIZED COMPARISON OF THE ANTIEMETIC EFFICACY OF 2INTRAVENOUS DOSES OF DOLASETRON MESILATE AND GRANISETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY

      European journal of cancer
    43. BLEIBERG H
      COLORECTAL-CANCER - THE CHALLENGE

      European journal of cancer
    44. BLEIBERG H; CVITKOVIC E
      CHARACTERIZATION AND CLINICAL MANAGEMENT OF CPT-11 (IRINOTECAN)-INDUCED ADVERSE EVENTS - THE EUROPEAN PERSPECTIVE

      European journal of cancer
    45. FAUSER AA; BLEIBERG H; CHEVALLIER B; FAVRE R; FABBRO M; NOBLE A; CUPISSOL D; DEGARDIN M; CAPPELAERE P; SPAETH D; CLAVERIE N
      A DOUBLE-BLIND, RANDOMIZED, PARALLEL STUDY OF IV DOLASETRON MESILATE VERSUS IV METOCLOPRAMIDE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY

      The Cancer journal
    46. BLIJHAM G; WAGENER T; WILS J; DEGREVE J; BUSET M; BLEIBERG H; LACAVE A; DALMARK M; SELLESLAG J; COLLETTE L; SAHMOUD T
      MODULATION OF HIGH-DOSE INFUSIONAL FLUOROURACIL BY LOW-DOSE METHOTREXATE IN PATIENTS WITH ADVANCED OR METASTATIC COLORECTAL-CANCER - FINAL RESULTS OF A RANDOMIZED EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT OF-CANCER STUDY

      Journal of clinical oncology
    47. CONROY T; ETIENNE PL; ADENIS A; WAGENER DJT; PAILLOT B; FRANCOIS E; BEDENNE L; JACOB JH; SEITZ JF; BLEIBERG H; VANPOTTELSBERGHE C; VANGLABBEKE M; DELGADO FM; MERLE S; WILS J
      PHASE-II TRIAL OF VINORELBINE IN METASTATIC SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA

      Journal of clinical oncology
    48. BLEIBERG H
      ROLE OF CHEMOTHERAPY FOR ADVANCED COLORECTAL-CANCER - NEW OPPORTUNITIES

      Seminars in oncology
    49. VANBELLE SJP; COCQUYT VFJ; BLEIBERG H; CANON JL; BUYSE M; HULSTAERT F; DEWITTE M; DEKEYSER P; WESTELINCK K
      OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

      Anti-cancer drugs
    50. LAZORTHES F; DUROCHER A; ESCAT J; FAIVRE J; GERARD JP; KLEPPING C; LOMBARDPLATET R; MALAFOSSE M; PIENKOWSKI P; ROUGIER P; BUGAT R; CABARROT P; GIGNOUX M; HOERNI B; LAGRANGE JL; MAGNIER AM; MARTIN P; MIGNON F; MONTANDON S; MOREAUX J; PELISSIER E; PICHON G; PIGNON JP; SOULIER Y; VEILBARAT C; VIARD H; ADLOFF M; BAULIEUX J; BLEIBERG H; BOSSET JF; CHIOTASSO P; DELPERO JR; DUBOIS JB; FOURTANIER G; HILDEBRANDT U; HORIOT JC; LASSER P; MARTY J; MORTENSEN N; NORDLINGER B; PARC R; REBOUL F; SEITZ JF; VALETTE PJ; WILLIAMS NS; COQUARD R; DECALAN L; DUCREUX M; GOUILLAT C; MOSNIER H; TIRET E
      SELECTION OF THERAPY FOR RECTAL-CANCER (D ECEMBER 1ST AND 2ND, 1994)

      Annales de Gastroenterologie et d'Hepatologie
    51. HENDLISZ A; BLEIBERG H
      DIAGNOSIS AND TREATMENT OF GASTRIC-CANCER

      Drugs
    52. BLEIBERG H; BODY JJ; BRON D; CULLUS D; GERAIN J; LOSSIGNOL D; RAZAVI D; SCULIER JP; THIRION M; KLASTERSKY J
      SUPPORTIVE CARE IN CANCER-PATIENTS

      Bailliere's clinical infectious diseases
    53. WILS J; BLEIBERG H; ROUGIER P
      ADJUVANT TREATMENT OF COLON-CANCER - A PLEA FOR A LARGE-SCALE EUROPEAN TRIAL

      European journal of cancer
    54. BLEIBERG H; AUTIER P; MICHAUX D
      COST-EFFECTIVENESS ANALYSIS OF ANTIEMETIC TREATMENT

      Supportive care in cancer
    55. VANBELLE SJP; STAMATAKIS L; BLEIBERG H; COCQUYT VFJ; MICHEL J; DEBRUIJN KM
      DOSE-FINDING STUDY OF TROPISETRON IN CISPLATIN-INDUCED NAUSEA AND VOMITING

      Annals of oncology
    56. HULSTAERT F; VANBELLE S; BLEIBERG H; CANON JL; DEWITTE M; BUYSE M; DEKEYSER P; WESTELINCK KJ
      OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

      Journal of clinical oncology
    57. BLEIBERG H
      THERAPY OF METASTATIC COLORECTAL CANCERS

      Pathologie et biologie
    58. TAAL BG; AUDISIO RA; BLEIBERG H; BLIJHAM GH; NEIJT JP; VEENHOF CHN; DUEZ N; SAHMOUD T
      PHASE-II TRIAL OF MITOMYCIN-C (MMC) IN ADVANCED GALLBLADDER AND BILIARY TREE CARCINOMA - AN EORTC GASTROINTESTINAL-TRACT-CANCER-COOPERATIVE-GROUP STUDY

      Annals of oncology
    59. BLEIBERG H; VANBELLE S; PARIDAENS R; DEWASCH G; DIRIX LY; TJEAN M
      COMPASSIONATE USE OF TROPISETRON IN PATIENTS AT HIGH-RISK OF SEVERE EMESIS

      Annals of oncology
    60. RAVOET C; BLEIBERG H; GERARD B
      NONSURGICAL TREATMENT OF HEPATOCARCINOMA

      Journal of surgical oncology
    61. BLEIBERG H
      NATURAL-HISTORY OF THE COLORECTAL-CANCER

      Bulletin du cancer
    62. GERARD A; PECTOR JC; VANHOUTTE P; BLEIBERG H
      ADJUVANT TREATMENTS IN RESECTABLE RECTAL-CANCER - PREOPERATIVE RADIOTHERAPY, POSTOPERATIVE RADIOTHERAPY CHEMOTHERAPY OR NOTHING

      Annales de chirurgie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 22:17:01